Davis's Drug Guide
ripretinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
rip-re-ti-nib
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Qinlock
Ther. Class.
Pharm. Class.
kinase inhibitors
platelet-derived growth factor receptor alpha blockers
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Ripretinib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580077/10/ripretinib.
Vallerand AHA, Sanoski CAC, . Ripretinib. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580077/10/ripretinib. Accessed April 22, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Ripretinib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580077/10/ripretinib
Vallerand AHA, Sanoski CAC, . Ripretinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 22]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580077/10/ripretinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ripretinib
ID - 3580077
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580077/10/ripretinib
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
